However, the number of premalignant lesions, MIN, do not decrease as consequence of the transition to carcinoma, nor the double myrAKT;p53(R172H) transgenic mice showed full penetrance phenotype despite broad expression of transgenes in mammary ducts. The gene discussed is TP53; the disease is carcinoma.